• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Tuesday

    6/6/22 2:11:51 PM ET
    $AFMD
    $AKAN
    $ALXO
    $AMZN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $AFMD alert in real time by email

     

    Monday's session saw 84 companies set new 52-week lows.

    Facts of Interest About Today's 52-Week Lows:

    • Amazon.com (NASDAQ:AMZN) was the biggest company in terms of market cap to set a new 52-week low.
    • The smallest company by market cap to set a new 52-week low was Scopus BioPharma (NASDAQ:SCPS).
    • Amazon.com (NASDAQ:AMZN)'s stock fell the most, as it traded down 94.81% to reach a new 52-week low.
    • Network-1 Technologies (AMEX:NTIP) was the most promising stock of the group, with shares actually trading up 0.0% to bounce back after reaching its new 52-week low.

    The following stocks set new 52-week lows on Monday:

    • Healthpeak Properties (NYSE:PEAK) shares hit a yearly low of $28.43. The stock was down 0.02% on the session.
    • MSP Recovery (NASDAQ:MSPR) stock hit a new 52-week low of $0.99. The stock was down 0.49% on the session.
    • Super Group (SGHC) (NYSE:SGHC) shares fell to $5.62 on Monday, setting a new 52-week low with a shift of down 9.4%.
    • Clearwater Analytics Hldg (NYSE:CWAN) shares made a new 52-week low of $13.44 on Monday. The stock was down 2.65% for the day.
    • Frontdoor (NASDAQ:FTDR) shares were down 1.16% for the day, having made a 52-week low of $23.75.
    • Canopy Gwth (NASDAQ:CGC) stock broke to a new 52-week low of $4.11 on Monday. Shares of the company traded down 4.51%.
    • Core Scientific (NASDAQ:CORZ) shares moved down 4.68% on Monday to hit a new 52-week low of $2.57, drifting down 4.68%.
    • Invitae (NYSE:NVTA) stock set a new 52-week low of $2.90 on Monday, moving down 1.42%.
    • IDT (NYSE:IDT) shares set a new yearly low of $25.33 this morning. The stock was down 7.37% on the session.
    • Embark Technology (NASDAQ:EMBK) shares were down 17.07% for the day, having made a 52-week low of $1.01.
    • Bright Green (NASDAQ:BGXX) stock hit a new 52-week low of $2.70. The stock was down 9.46% on the session.
    • Affimed (NASDAQ:AFMD) shares set a new 52-week low of $2.88. The stock traded down 6.18%.
    • Bicycle Therapeutics (NASDAQ:BCYC) stock hit $13.98 on Monday morning, setting a new 52-week low for a change of down 7.09%.
    • Velo3D (NYSE:VLD) shares set a new 52-week low of $2.09. The stock traded down 5.58%.
    • BuzzFeed (NASDAQ:BZFD) shares set a new 52-week low of $2.50. The stock traded down 32.71%.
    • Innovid (NYSE:CTV) shares made a new 52-week low of $2.46 on Monday. The stock was down 9.64% for the day.
    • BARK (NYSE:BARK) stock drifted down 8.87% on Monday morning to hit a new 52-week low of $1.67.
    • Heron Therapeutics (NASDAQ:HRTX) shares made a new 52-week low of $2.84 on Monday. The stock was down 5.0% for the day.
    • ALX Oncology Holdings (NASDAQ:ALXO) shares set a new yearly low of $7.04 this morning. The stock was down 7.37% on the session.
    • Lesaka Technologies (NASDAQ:LSAK) shares reached a new 52-week low of $3.90 on Monday morning, moving down 3.41%.
    • NextNav (NASDAQ:NN) shares hit a yearly low of $2.85. The stock was down 4.35% on the session.
    • Latch (NASDAQ:LTCH) shares moved down 9.02% on Monday to hit a new 52-week low of $1.79, drifting down 9.02%.
    • OraSure Technologies (NASDAQ:OSUR) stock set a new 52-week low of $3.36 on Monday, moving down 8.07%.
    • Burning Rock Biotech (NASDAQ:BNR) shares moved down 1.28% on Monday to hit a new 52-week low of $2.29, drifting down 1.28%.
    • Sophia Genetics (NASDAQ:SOPH) stock dropped to a yearly low on Monday of $3.50. Shares traded down 0.54%.
    • Theseus Pharmaceuticals (NASDAQ:THRX) stock drifted down 4.74% on Monday morning to hit a new 52-week low of $5.66.
    • Macrogenics (NASDAQ:MGNX) shares set a new yearly low of $3.14 this morning. The stock was down 5.69% on the session.
    • Tactile Systems Tech (NASDAQ:TCMD) stock broke to a new 52-week low of $8.15 on Monday. Shares of the company traded down 17.89%.
    • Zenvia (NASDAQ:ZENV) shares set a new yearly low of $3.52 this morning. The stock was down 0.27% on the session.
    • Omeros (NASDAQ:OMER) shares set a new 52-week low of $2.26. The stock traded down 9.0%.
    • Praxis Precision Medicine (NASDAQ:PRAX) shares moved down 65.77% on Monday to hit a new 52-week low of $2.77, drifting down 65.77%.
    • First Cap (NASDAQ:FCAP) shares were down 0.22% for the day, having made a 52-week low of $33.00.
    • Romeo Power (NYSE:RMO) stock achieved a new 52-week low on Monday morning, hitting $0.70 and moving up 0.01%.
    • IMV (NASDAQ:IMV) shares set a new 52-week low of $0.88. The stock traded down 1.93%.
    • Mustang Bio (NASDAQ:MBIO) stock hit a new 52-week low of $0.59. The stock was down 4.66% on the session.
    • Kirkland's (NASDAQ:KIRK) shares made a new 52-week low of $4.57 on Monday. The stock was up 0.49% for the day.
    • Network-1 Technologies (AMEX:NTIP) shares set a new 52-week low of $2.32. The stock traded 0.0% (flat).
    • Boxlight (NASDAQ:BOXL) shares set a new 52-week low of $0.79. The stock traded down 2.69%.
    • Visionary Education Tech (NASDAQ:VEDU) shares were down 2.24% for the day, having made a 52-week low of $1.28.
    • S&W Seed (NASDAQ:SANW) shares hit a yearly low of $1.18. The stock was down 2.44% on the session.
    • BioVie (NASDAQ:BIVI) stock set a new 52-week low of $1.92 on Monday, moving down 2.02%.
    • Biote (NASDAQ:BTMD) stock hit $4.15 on Monday morning, setting a new 52-week low for a change of down 15.82%.
    • Dawson Geophysical (NASDAQ:DWSN) stock broke to a new 52-week low of $1.55 on Monday. Shares of the company traded down 2.99%.
    • Bit Origin (NASDAQ:BTOG) shares were down 0.36% for the day, having made a 52-week low of $0.47.
    • cbdMD (AMEX:YCBD) shares fell to $0.49 on Monday, setting a new 52-week low with a shift of down 2.57%.
    • Tenon Medical (NASDAQ:TNON) shares moved down 1.27% on Monday to hit a new 52-week low of $2.86, drifting down 1.27%.
    • Spero Therapeutics (NASDAQ:SPRO) stock broke to a new 52-week low of $1.00 on Monday. Shares of the company traded down 1.92%.
    • Applied Therapeutics (NASDAQ:APLT) stock hit a yearly low of $1.15. The stock was down 5.28% for the day.
    • Regis (NYSE:RGS) stock broke to a new 52-week low of $0.62 on Monday. Shares of the company traded down 0.57%.
    • Cidara Therapeutics (NASDAQ:CDTX) shares were up 0.07% for the day, having made a 52-week low of $0.40.
    • Pennsylvania REIT (NYSE:PEI) shares fell to $0.33 on Monday, setting a new 52-week low with a shift of down 4.52%.
    • ASLAN Pharma (NASDAQ:ASLN) stock hit $0.36 on Monday morning, setting a new 52-week low for a change of down 0.54%.
    • Marker Therapeutics (NASDAQ:MRKR) shares moved down 3.78% on Monday to hit a new 52-week low of $0.27, drifting down 3.78%.
    • Akanda (NASDAQ:AKAN) shares set a new 52-week low of $0.79. The stock traded down 5.1%.
    • Panbela Therapeutics (NASDAQ:PBLA) shares were up 5.0% for the day, having made a 52-week low of $1.36.
    • Meiwu Technology Co (NASDAQ:WNW) shares fell to $0.58 on Monday, setting a new 52-week low with a shift of down 14.84%.
    • Blackboxstocks (NASDAQ:BLBX) shares hit a yearly low of $1.38. The stock was down 2.11% on the session.
    • Shineco (NASDAQ:SISI) shares fell to $1.49 on Monday, setting a new 52-week low with a shift of down 3.87%.
    • Safe-T Gr (NASDAQ:SFET) stock achieved a new 52-week low on Monday morning, hitting $0.47 and moving down 4.34%.
    • Gaucho Group Holdings (NASDAQ:VINO) stock broke to a new 52-week low of $0.91 on Monday. Shares of the company traded down 9.68%.
    • Sobr Safe (NASDAQ:SOBR) stock achieved a new 52-week low on Monday morning, hitting $0.84 and moving down 13.72%.
    • Aclarion (NASDAQ:ACON) stock dropped to a yearly low on Monday of $1.01. Shares traded down 4.94%.
    • Scopus BioPharma (NASDAQ:SCPS) shares reached a new 52-week low of $0.34 on Monday morning, moving down 9.23%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $AFMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFMD
    $AKAN
    $ALXO
    $AMZN

    CompanyDatePrice TargetRatingAnalyst
    Amazon.com Inc.
    $AMZN
    2/6/2026$300.00 → $280.00Buy
    Monness Crespi & Hardt
    Amazon.com Inc.
    $AMZN
    2/6/2026$175.00Buy → Neutral
    DA Davidson
    Amazon.com Inc.
    $AMZN
    2/2/2026$300.00 → $315.00Mkt Outperform
    Citizens JMP
    Praxis Precision Medicines Inc.
    $PRAX
    2/2/2026$282.00Equal Weight
    Wells Fargo
    Amazon.com Inc.
    $AMZN
    1/28/2026$305.00 → $315.00Outperform
    Oppenheimer
    Amazon.com Inc.
    $AMZN
    1/28/2026$303.00 → $308.00Overweight
    KeyBanc Capital Markets
    Amazon.com Inc.
    $AMZN
    1/27/2026$295.00 → $300.00Buy
    Stifel
    Amazon.com Inc.
    $AMZN
    1/27/2026$303.00 → $286.00Buy
    BofA Securities
    More analyst ratings

    $AFMD
    $AKAN
    $ALXO
    $AMZN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFMD
    $AKAN
    $ALXO
    $AMZN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Goodman Corey S bought $4,999,999 worth of shares (3,184,713 units at $1.57) (SEC Form 4)

    4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)

    2/4/26 4:15:59 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    President & CEO Stein Jeffrey disposed of $339,040 worth of shares (5,190 units at $65.33), bought $339,040 worth of shares (4,262 units at $79.55), gifted 1,873 shares and received a gift of 937 shares, decreasing direct ownership by 44% to 5,763 units (SEC Form 4)

    4 - Cidara Therapeutics, Inc. (0001610618) (Issuer)

    1/7/26 8:12:25 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AFMD
    $AKAN
    $ALXO
    $AMZN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amazon.com Announces Fourth Quarter Results

    Amazon.com, Inc. (NASDAQ:AMZN) today announced financial results for its fourth quarter ended December 31, 2025. Fourth Quarter 2025 Net sales increased 14% to $213.4 billion in the fourth quarter, compared with $187.8 billion in fourth quarter 2024. Excluding the $2.8 billion favorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 12% compared with fourth quarter 2024. North America segment sales increased 10% year-over-year to $127.1 billion. International segment sales increased 17% year-over-year to $50.7 billion, or increased 11% excluding changes in foreign exchange rates. AWS segment sales increased 24% year-over

    2/5/26 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Clearwater Analytics and TreasurySpring Announce Platform Integration for Fixed-Term Cash Management

    Integration Enables Institutional Clients to Optimize Surplus Cash Returns with Predictable Maturity Matching Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management and TreasurySpring, the global cash investment platform, today announced an integration that connects CWAN's investment management platform directly with over 1,000 cash investment products from TreasurySpring, helping institutional clients manage surplus cash with defined maturity requirements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205846318/en/ Through TreasurySpring, institutional clients can: Optimi

    2/5/26 9:00:00 AM ET
    $CWAN
    Computer Software: Prepackaged Software
    Technology

    Regis Corporation Reports Financial Results for the Second Fiscal Quarter 2026

    Transformation Efforts Gain Traction Across Supercuts and Corporate Networks Q2 Same-Store Sales for Supercuts Up 2.0%, Company-Owned Salons up 4.3%, Regis Consolidated Slightly Lower as Expected Due to Franchise Mix Loyalty Membership Enrollment Grows Steadily Regis Corporation (NASDAQGM:RGS), a leader in the haircare industry, today announced financial results for the second fiscal quarter ended December 31, 2025. Jim Lain, Regis Corporation's Interim President and Chief Executive Officer, commented, "Our second quarter results demonstrate improved execution and continued momentum, with same-store sales increasing 2.0% at Supercuts and 4.3% at company-owned salons. We delivered ye

    2/5/26 6:30:00 AM ET
    $RGS
    Other Consumer Services
    Consumer Discretionary

    $AFMD
    $AKAN
    $ALXO
    $AMZN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Monness Crespi & Hardt reiterated coverage on Amazon with a new price target

    Monness Crespi & Hardt reiterated coverage of Amazon with a rating of Buy and set a new price target of $280.00 from $300.00 previously

    2/6/26 8:23:18 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amazon downgraded by DA Davidson with a new price target

    DA Davidson downgraded Amazon from Buy to Neutral and set a new price target of $175.00

    2/6/26 8:06:19 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Citizens JMP reiterated coverage on Amazon with a new price target

    Citizens JMP reiterated coverage of Amazon with a rating of Mkt Outperform and set a new price target of $315.00 from $300.00 previously

    2/2/26 8:12:32 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AFMD
    $AKAN
    $ALXO
    $AMZN
    SEC Filings

    View All

    SEC Form EFFECT filed by Applied Therapeutics Inc.

    EFFECT - Applied Therapeutics, Inc. (0001697532) (Filer)

    2/9/26 12:15:09 AM ET
    $APLT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form EFFECT filed by Applied Therapeutics Inc.

    EFFECT - Applied Therapeutics, Inc. (0001697532) (Filer)

    2/9/26 12:15:13 AM ET
    $APLT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by BioVie Inc.

    10-Q - BIOVIE INC. (0001580149) (Filer)

    2/6/26 5:01:18 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFMD
    $AKAN
    $ALXO
    $AMZN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Booth Jeffrey David was granted 18,575 shares, increasing direct ownership by 9% to 214,262 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    2/6/26 4:11:54 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Director Crain Elizabeth was granted 18,575 shares, increasing direct ownership by 40% to 65,348 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    2/6/26 4:11:51 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Director Rozov Yadin was granted 18,575 shares, increasing direct ownership by 4% to 454,162 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    2/6/26 4:11:49 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    $AFMD
    $AKAN
    $ALXO
    $AMZN
    Financials

    Live finance-specific insights

    View All

    Amazon.com Announces Fourth Quarter Results

    Amazon.com, Inc. (NASDAQ:AMZN) today announced financial results for its fourth quarter ended December 31, 2025. Fourth Quarter 2025 Net sales increased 14% to $213.4 billion in the fourth quarter, compared with $187.8 billion in fourth quarter 2024. Excluding the $2.8 billion favorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 12% compared with fourth quarter 2024. North America segment sales increased 10% year-over-year to $127.1 billion. International segment sales increased 17% year-over-year to $50.7 billion, or increased 11% excluding changes in foreign exchange rates. AWS segment sales increased 24% year-over

    2/5/26 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Regis Corporation Reports Financial Results for the Second Fiscal Quarter 2026

    Transformation Efforts Gain Traction Across Supercuts and Corporate Networks Q2 Same-Store Sales for Supercuts Up 2.0%, Company-Owned Salons up 4.3%, Regis Consolidated Slightly Lower as Expected Due to Franchise Mix Loyalty Membership Enrollment Grows Steadily Regis Corporation (NASDAQGM:RGS), a leader in the haircare industry, today announced financial results for the second fiscal quarter ended December 31, 2025. Jim Lain, Regis Corporation's Interim President and Chief Executive Officer, commented, "Our second quarter results demonstrate improved execution and continued momentum, with same-store sales increasing 2.0% at Supercuts and 4.3% at company-owned salons. We delivered ye

    2/5/26 6:30:00 AM ET
    $RGS
    Other Consumer Services
    Consumer Discretionary

    Clearwater Analytics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

    Clearwater Analytics Holdings, Inc. (NYSE:CWAN), ("CWAN" or the "Company"), the most comprehensive technology platform for investment management, will release financial results for the fourth quarter and full year ended December 31, 2025 after the U.S. financial markets close on Wednesday, February 18, 2026. As a result of the execution of a definitive agreement under which an investor group led by Permira and Warburg Pincus will acquire all of the outstanding shares of the Company's common stock in an all-cash transaction, as announced on December 21, 2025, the Company will not host an earnings conference call or webcast to discuss its fourth quarter and full year 2025 financial results

    2/4/26 4:15:00 PM ET
    $CWAN
    Computer Software: Prepackaged Software
    Technology

    $AFMD
    $AKAN
    $ALXO
    $AMZN
    Leadership Updates

    Live Leadership Updates

    View All

    Hasbro Announces Additions to Board of Directors

    Doug Bowser and Carla Vernón to join as newest Board members Today, Hasbro, Inc. (NASDAQ:HAS), a leading games, IP and toy company, announced that Doug Bowser, retired President and Chief Operating Officer of Nintendo of America Inc., and Carla Vernón, Chief Executive Officer of The Honest Company, Inc. have been appointed to Hasbro's Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120899535/en/ "We are delighted to have Doug and Carla join our seasoned and dynamic Board of Directors," said Rich Stoddart, Chair of Hasbro's Board of Directors. "Doug and Carla bring extensive leadership experience across co

    1/20/26 8:30:00 AM ET
    $AMZN
    $GIS
    $HAS
    Catalog/Specialty Distribution
    Consumer Discretionary
    Packaged Foods
    Consumer Staples

    Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy

    BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced the appointment of world-renowned neurologist and epilepsy authority Dr. Orrin Devinsky, M.D., as Head of Clinical Strategy, a newly created leadership role. Dr. Devinsky is widely regarded as one of the most influential physician-scientists of his generation in modern epilepsy and clinical neuroscience. Over a career spanning more than four decades, he has shaped the development of multiple transformative therapies, built enduring global research initiatives, and helped define t

    1/13/26 4:30:00 PM ET
    $PRAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments

    BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation–inhibition imbalance, today announced the appointment of Jeffrey B. Kindler and Stuart Arbuckle to its board of directors, and the promotions of Megan Sniecinski to Chief Operating Officer and Dr. Steven Petrou to President of Research & Development. "These leadership decisions reflect a deliberate evolution of Praxis as we enter a phase driven by commercial launch planning and execution readiness, late-stage developm

    1/8/26 4:45:00 PM ET
    $PRAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFMD
    $AKAN
    $ALXO
    $AMZN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Bicycle Therapeutics plc

    SC 13D/A - BICYCLE THERAPEUTICS PLC (0001761612) (Subject)

    12/17/24 6:46:27 PM ET
    $BCYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Latch Inc.

    SC 13G - Latch, Inc. (0001826000) (Subject)

    12/13/24 9:45:09 PM ET
    $LTCH
    EDP Services
    Technology

    SEC Form SC 13G filed by Cidara Therapeutics Inc.

    SC 13G - Cidara Therapeutics, Inc. (0001610618) (Subject)

    12/9/24 5:37:15 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care